Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients who have metastatic or recurrent colorectal cancer.

Timeline

Start

1996-09

Primary completion

2000-07

Completion

2001-01

Drugs

Indications